Michael-Jubeli R et al. |
High-temperature gas chromatography-mass spectrometry for skin surface lipids profiling. |
2011 |
J. Lipid Res. |
pmid:20952798
|
Lama-Muñoz A et al. |
New hydrothermal treatment of alperujo enhances the content of bioactive minor components in crude pomace olive oil. |
2011 |
J. Agric. Food Chem. |
pmid:21265536
|
Cen-Pacheco F et al. |
Cytotoxic oxasqualenoids from the red alga Laurencia viridis. |
2011 |
Eur J Med Chem |
pmid:21616566
|
Raouane M et al. |
Synthesis, characterization, and in vivo delivery of siRNA-squalene nanoparticles targeting fusion oncogene in papillary thyroid carcinoma. |
2011 |
J. Med. Chem. |
pmid:21561161
|
Nowosielski M and Hoffmann M |
Do the substituent effects affect conformational freedom of squalene in hopene biosynthesis? |
2011 |
J Mol Model |
pmid:21562825
|
Hernández-GarcÃa I et al. |
[Adverse events after administration of A/H1N1 vaccine to patients]. |
2011 |
Med Clin (Barc) |
pmid:20199781
|
Fox CB et al. |
Effects of emulsifier concentration, composition, and order of addition in squalene-phosphatidylcholine oil-in-water emulsions. |
2011 |
Pharm Dev Technol |
pmid:20550484
|
Celia C et al. |
Gemcitabine-loaded innovative nanocarriers vs GEMZAR: biodistribution, pharmacokinetic features and in vivo antitumor activity. |
2011 |
Expert Opin Drug Deliv |
pmid:22077480
|
Tsai TF |
MF59 adjuvanted seasonal and pandemic influenza vaccines. |
2011 |
Yakugaku Zasshi |
pmid:22129867
|
Puig-Barberà J et al. |
MF59â„¢-adjuvanted seasonal influenza vaccine in young children. |
2011 |
Expert Rev Vaccines |
pmid:22043952
|
Viganò A et al. |
Long-term immunogenicity after one and two doses of a monovalent MF59-adjuvanted A/H1N1 Influenza virus vaccine coadministered with the seasonal 2009-2010 nonadjuvanted Influenza virus vaccine in HIV-infected children, adolescents, and young adults in a randomized controlled trial. |
2011 |
Clin. Vaccine Immunol. |
pmid:21795458
|
Huijskens E et al. |
Immunogenicity, boostability, and sustainability of the immune response after vaccination against Influenza A virus (H1N1) 2009 in a healthy population. |
2011 |
Clin. Vaccine Immunol. |
pmid:21795459
|
Pollard AJ and Hill AV |
Antibody repertoire: embracing diversity. |
2011 |
Sci Transl Med |
pmid:21795586
|
Okike IO et al. |
The immunogenicity of a novel A (H1N1) vaccine in HIV-infected children. |
2011 |
Vaccine |
pmid:21742005
|
Kowert BA and Watson MB |
Diffusion of organic solutes in squalane. |
2011 |
J Phys Chem B |
pmid:21780767
|
Andrews N et al. |
Age-specific effectiveness of an oil-in-water adjuvanted pandemic (H1N1) 2009 vaccine against confirmed infection in high risk groups in England. |
2011 |
J. Infect. Dis. |
pmid:21148494
|
Kajaste-Rudnitski A et al. |
Induction of protective antibody response by MF59-adjuvanted 2009 pandemic A/H1N1v influenza vaccine in HIV-1-infected individuals. |
2011 |
AIDS |
pmid:21150561
|
Launay O et al. |
Safety and immunogenicity of a monovalent 2009 influenza A/H1N1v vaccine adjuvanted with AS03A or unadjuvanted in HIV-infected adults: a randomized, controlled trial. |
2011 |
J. Infect. Dis. |
pmid:21628666
|
Piccialli V et al. |
Isolation of a bis-iodurated tetra-THF as a trace product from the oxidation of squalene with RuOâ‚„ and its double ring expansion to a novel bis-THF-bis-THP compound. |
2011 |
Molecules |
pmid:21709619
|
Iannazzo S |
Pharmacoeconomic evaluation of the MF59--adjuvanted influenza vaccine in the elderly population in Italy. |
2011 |
J Prev Med Hyg |
pmid:21710816
|
Seubert A et al. |
Adjuvanticity of the oil-in-water emulsion MF59 is independent of Nlrp3 inflammasome but requires the adaptor protein MyD88. |
2011 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:21690334
|
Khurana S et al. |
MF59 adjuvant enhances diversity and affinity of antibody-mediated immune response to pandemic influenza vaccines. |
2011 |
Sci Transl Med |
pmid:21632986
|
Zhang LW et al. |
Oil components modulate the skin delivery of 5-aminolevulinic acid and its ester prodrug from oil-in-water and water-in-oil nanoemulsions. |
2011 |
Int J Nanomedicine |
pmid:21556344
|
Esposito S et al. |
Immunogenicity, safety and tolerability of monovalent 2009 pandemic influenza A/H1N1 MF59-adjuvanted vaccine in children and adolescents with Williams or Cornelia De Lange syndrome. |
2011 |
Hum Vaccin |
pmid:21508673
|
AÄimoviÄ J et al. |
Circadian rhythm of cholesterol synthesis in mouse liver: a statistical analysis of the post-squalene metabolites in wild-type and Crem-knock-out mice. |
2011 |
Biochem. Biophys. Res. Commun. |
pmid:21531203
|
Siedenburg G and Jendrossek D |
Squalene-hopene cyclases. |
2011 |
Appl. Environ. Microbiol. |
pmid:21531832
|
Tsai TF et al. |
Explorations of clinical trials and pharmacovigilance databases of MF59®-adjuvanted influenza vaccines for associated cases of narcolepsy. |
2011 |
Scand. J. Infect. Dis. |
pmid:21534891
|
Esposito S et al. |
Influenza A/H1N1 MF59-adjuvanted vaccine in preterm and term children aged 6 to 23 months. |
2011 |
Pediatrics |
pmid:21464195
|
Esposito S et al. |
An open-label, randomized clinical trial assessing immunogenicity, safety and tolerability of pandemic influenza A/H1N1 MF59-adjuvanted vaccine administered sequentially or simultaneously with seasonal virosomal-adjuvanted influenza vaccine to paediatric kidney transplant recipients. |
2011 |
Nephrol. Dial. Transplant. |
pmid:20974645
|
Durando P et al. |
Adjuvants and alternative routes of administration towards the development of the ideal influenza vaccine. |
2011 Jan-Feb |
Hum Vaccin |
pmid:21245655
|
Schellenberger MT et al. |
Evaluation of adjuvants for a candidate conjugate vaccine against benzo[a]pyrene. |
2011 Jan-Feb |
Hum Vaccin |
pmid:21245662
|
Dorea JG |
Safety of thimerosal in vaccines: for whom and how many doses? |
2011 Mar-Apr |
Therapie |
pmid:23189333
|
Kozlov VG and Viktorova EG |
[Evaluation of the efficiency and reactogenicity of emulsion-based adjuvant systems in the manufacture of polyclonal enteroviral diagnostic sera]. |
2011 Mar-Apr |
Vopr. Virusol. |
pmid:21545042
|
Della Cioppa G et al. |
Superior immunogenicity of seasonal influenza vaccines containing full dose of MF59 (®) adjuvant: results from a dose-finding clinical trial in older adults. |
2012 |
Hum Vaccin Immunother |
pmid:22426371
|
Ikematsu H et al. |
Evaluation of immune response following one dose of an AS03A-adjuvanted H1N1 2009 pandemic influenza vaccine in Japanese adults 65 years of age or older. |
2012 |
Hum Vaccin Immunother |
pmid:22854661
|
Nakazawa A et al. |
Optimization of culture conditions of the thraustochytrid Aurantiochytrium sp. strain 18W-13a for squalene production. |
2012 |
Bioresour. Technol. |
pmid:22023965
|
Niehaus TD et al. |
Functional identification of triterpene methyltransferases from Botryococcus braunii race B. |
2012 |
J. Biol. Chem. |
pmid:22241476
|
Iorio AM et al. |
Influenza viruses and cross-reactivity in healthy adults: humoral and cellular immunity induced by seasonal 2007/2008 influenza vaccination against vaccine antigens and 2009 A(H1N1) pandemic influenza virus. |
2012 |
Vaccine |
pmid:22245606
|
Sémiramoth N et al. |
Self-assembled squalenoylated penicillin bioconjugates: an original approach for the treatment of intracellular infections. |
2012 |
ACS Nano |
pmid:22482704
|
Langley JM et al. |
Safety and immunogenicity of 2010-2011 H1N12009-containing trivalent inactivated influenza vaccine in children 12-59 months of age previously given AS03-adjuvanted H1N12009 pandemic vaccine: a PHAC/CIHR Influenza Research Network (PCIRN) study. |
2012 |
Vaccine |
pmid:22469860
|
Fukase H et al. |
Assessment of the immunogenicity and safety of varying doses of an MF59®-adjuvanted cell culture-derived A/H1N1 pandemic influenza vaccine in Japanese paediatric, adult and elderly subjects. |
2012 |
Vaccine |
pmid:22472791
|
Suthiwong J et al. |
A new phenolic compound from the stem of Hymenocardia wallichii. |
2012 |
J Asian Nat Prod Res |
pmid:22423644
|
Zhang XH et al. |
Chemical composition of volatile oils from the pericarps of Indian sandalwood (Santalum album) by different extraction methods. |
2012 |
Nat Prod Commun |
pmid:22428257
|
Guzmán Herrador BR et al. |
Usefulness of health registries when estimating vaccine effectiveness during the influenza A(H1N1)pdm09 pandemic in Norway. |
2012 |
BMC Infect. Dis. |
pmid:22429643
|
Hatz C et al. |
A randomized clinical trial to identify the optimal antigen and MF59(®) adjuvant dose of a monovalent A/H1N1 pandemic influenza vaccine in healthy adult and elderly subjects. |
2012 |
Vaccine |
pmid:22446638
|
Desmaële D et al. |
Squalenoylation: a generic platform for nanoparticular drug delivery. |
2012 |
J Control Release |
pmid:21840355
|
Naziri E et al. |
Recovery of squalene from wine lees using ultrasound assisted extraction-a feasibility study. |
2012 |
J. Agric. Food Chem. |
pmid:22888984
|
Czajka H et al. |
A phase II, randomised clinical trial to demonstrate the non-inferiority of low-dose MF59-adjuvanted pre-pandemic A/H5N1 influenza vaccine in adult and elderly subjects. |
2012 |
J Prev Med Hyg |
pmid:23362618
|
Takami T et al. |
A genetic and pharmacological analysis of isoprenoid pathway by LC-MS/MS in fission yeast. |
2012 |
PLoS ONE |
pmid:23145048
|
Langley JM et al. |
A randomized, controlled non-inferiority trial comparing A(H1N1)pmd09 vaccine antigen, with and without AS03 adjuvant system, co-administered or sequentially administered with an inactivated trivalent seasonal influenza vaccine. |
2012 |
BMC Infect. Dis. |
pmid:23110320
|